These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 34364043)

  • 21. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
    Dzobo K; Chiririwa H; Dandara C; Dzobo W
    OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical trial of IL-15 and IL-21 combination therapy for COVID-19 is warranted.
    Wilz SW
    Cytokine Growth Factor Rev; 2021 Apr; 58():49-50. PubMed ID: 33199178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tocilizumab improves survival in severe COVID-19 pneumonia with persistent hypoxia: a retrospective cohort study with follow-up from Mumbai, India.
    Gokhale Y; Mehta R; Kulkarni U; Karnik N; Gokhale S; Sundar U; Chavan S; Kor A; Thakur S; Trivedi T; Kumar N; Baveja S; Wadal A; Kolte S; Deolankar A; Pednekar S; Kalekar L; Padiyar R; Londhe C; Darole P; Pol S; Gokhe SB; Padwal N; Pandey D; Yadav D; Joshi A; Badgujar H; Trivedi M; Shah P; Bhavsar P
    BMC Infect Dis; 2021 Mar; 21(1):241. PubMed ID: 33673818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effects of interleukin-1β and interleukin-17A antibodies on collagen-induced arthritis mouse model.
    Zhang Y; Ren G; Guo M; Ye X; Zhao J; Xu L; Qi J; Kan F; Liu M; Li D
    Int Immunopharmacol; 2013 Feb; 15(2):199-205. PubMed ID: 23280345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-17 Aggravates
    Ding F; Han L; Fu Q; Fan X; Tang R; Lv C; Xue Y; Tian X; Zhang M
    Front Immunol; 2021; 12():811803. PubMed ID: 35095906
    [No Abstract]   [Full Text] [Related]  

  • 26. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.
    Chau AS; Weber AG; Maria NI; Narain S; Liu A; Hajizadeh N; Malhotra P; Bloom O; Marder G; Kaplan B
    Arthritis Rheumatol; 2021 Jan; 73(1):23-35. PubMed ID: 32929876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine storm and the prospects for immunotherapy with COVID-19.
    Calabrese LH
    Cleve Clin J Med; 2020 Jun; 87(7):389-393. PubMed ID: 32393592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease.
    Zhou Z; Price CC
    Expert Opin Investig Drugs; 2020 Dec; 29(12):1407-1412. PubMed ID: 33094669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum level of interleukin-17A in patients with alopecia areata and its relationship to age.
    El-Morsy EH; Eid AA; Ghoneim H; Al-Tameemi KA
    Int J Dermatol; 2016 Aug; 55(8):869-74. PubMed ID: 26475394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of redundant Th17 cells and IL-17A, but not IL-17 F, with the severity of obstructive sleep apnoea/hypopnoea syndrome (OSAHS).
    Ying L; Li H; Pan Z; Ma S; Zhang P; Wang Q; Lu G; Zhou J
    BMC Pulm Med; 2014 May; 14():84. PubMed ID: 24885744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Small" Intestinal Immunopathology Plays a "Big" Role in Lethal Cytokine Release Syndrome, and Its Modulation by Interferon-γ, IL-17A, and a Janus Kinase Inhibitor.
    Kale SD; Mehrkens BN; Stegman MM; Kastelberg B; Carnes H; McNeill RJ; Rizzo A; Karyala SV; Coutermarsh-Ott S; Fretz JA; Sun Y; Koff JL; Rajagopalan G
    Front Immunol; 2020; 11():1311. PubMed ID: 32676080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
    Macciò A; Oppi S; Madeddu C
    J Ovarian Res; 2021 Feb; 14(1):28. PubMed ID: 33550983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
    Shibabaw T
    J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management.
    Sunkara H; Dewan SMR
    Int Immunopharmacol; 2021 Oct; 99():108049. PubMed ID: 34426104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Involvement of the complement cascade in severe forms of COVID-19].
    Chouaki Benmansour N; Carvelli J; Vivier É
    Med Sci (Paris); 2021 Apr; 37(4):333-341. PubMed ID: 33835019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Th17 cells are associated with protection from ventilator associated pneumonia.
    Orlov M; Dmyterko V; Wurfel MM; Mikacenic C
    PLoS One; 2017; 12(8):e0182966. PubMed ID: 28806403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19.
    Ali A; Kamjani MH; Kesselman MM
    Recent Pat Antiinfect Drug Discov; 2020; 15(2):104-112. PubMed ID: 32962623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review.
    Antwi-Amoabeng D; Kanji Z; Ford B; Beutler BD; Riddle MS; Siddiqui F
    J Med Virol; 2020 Nov; 92(11):2516-2522. PubMed ID: 32436994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.